SCHEMBL4557441

SCHEMBL4557441

NC(=O)c1nn[nH]c1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
UMPS P11172 1/20 0.52
SMN1; SMN2 Q16637 3/20 0.42
KDM4E B2RXH2 2/20 0.42
ALDH1A1 P00352 2/20 0.42
TSHR P16473 2/20 0.42
TDP1 Q9NUW8 1/20 0.42
GAA P10253 1/20 0.42
HTT P42858 1/20 0.42
BLM P54132 1/20 0.42
TP53 P04637 1/20 0.42
MAPT P10636 1/20 0.42
PYGL P06737 2/20 0.38
LMNA P02545 3/20 0.38
GLA P06280 1/20 0.38
EIF4E P06730 1/20 0.38
CYP3A4 P08684 1/20 0.38
TOP1 P11387 1/20 0.38
ADORA1 P30542 1/20 0.38
THPO P40225 1/20 0.38
PMP22 Q01453 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21539496 1.00 UMPS (0.52) UMPSSMN1; SMN2KDM4EALDH1A1TSHR
SCHEMBL6772575 0.87 UMPS (0.44) UMPSPYGLPNPPAX8
SCHEMBL22235673 0.80 UMPS (0.54) UMPSSMN1; SMN2KDM4EALDH1A1TSHR
Pyrazofurin SCHEMBL21379808 0.80 UMPS (0.61) UMPSSMN1; SMN2KDM4EALDH1A1TSHR
SCHEMBL5795431 0.80 UMPS (0.54) UMPSSMN1; SMN2KDM4EALDH1A1TSHR
Pyrazofurin SCHEMBL28176565 0.78 UMPS (0.60) UMPSSMN1; SMN2KDM4EALDH1A1TSHR
Pyrazofurin SCHEMBL28138546 0.77 UMPS (0.58) UMPSSMN1; SMN2KDM4EALDH1A1TSHR
SCHEMBL15820221 0.77 UMPS (0.47) UMPSPYGL
SCHEMBL9051201 0.76 UMPS (0.51) UMPSSMN1; SMN2KDM4EALDH1A1TSHR
SCHEMBL30573140 0.74 UMPS (0.48) UMPSSMN1; SMN2KDM4EALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2067034-A2 EIF4E REGULON-BASED DIAGNOSTICS Translational Therapeutics, Inc. (US) 2009-06-10 EP disclosed
EP-1971690-A2 TRANSLATIONAL DYSFUNCTION BASED THERAPEUTICS Translational Therapeutics (US) 2008-09-24 EP disclosed
WO-2008060369-A2 EIF4E REGULON-BASED DIAGNOSTICS TRANSLATIONAL THERAPEUTICS, INC. (US) 2008-05-22 WO disclosed
WO-2007123579-A2 TRANSLATIONAL DYSFUNCTION BASED THERAPEUTICS TRANSLATIONAL THERAPEUTICS (US) 2007-11-01 WO disclosed
US-5071839-A Polysaccharides of wang qi and ginsengoside LIU YAGUANG (US) 1991-12-10 US disclosed